(Q71015621)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

K J Hellestrand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

83A-88A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Summary of efficacy and safety of flecainide for supraventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Flecainide in quinidine-resistant atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Long-term efficacy and safety of flecainide for supraventricular tachycardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

Long-term safety and efficacy of flecainide in the treatment of supraventricular tachyarrhythmias: the United States experience. The Flecainide Supraventricular Tachyarrhythmia Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989122-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(97)89122-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8607396%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference